HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Norbolethone
Wy-3475 · Genabol · Dl-norbolethone · 3-Ethyl-17-hydroxy-18,19-dinor-pregn-4-en-3-one · (17S)-13ξ-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-3-one · Dl-13-beta,17-alpha-diethyl-17-beta-hydroxygon-4-en-3-one · 18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17α)-(±)- · (8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

Identifikatoren & physikalische Daten
| CAS No. | 1235-15-0 |
|---|---|
| Summenformel | C21H32O2 |
| Durchschnittliche Molmasse | 316,5 g/mol |
| SMILES | CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC |
| InChIKey | FTBJKONNNSKOLX-XUDSTZEESA-N |
| PubChem CID | 66255 |
| ChEMBL | CHEMBL2105134 |
| DTXSID | DTXSID50154027 |
Chemische & physikalische Eigenschaften
| XLogP | 3,8 |
|---|---|
| Polarare Oberfläche (TPSA) | 37,3 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 2 |
| Frei drehbare Bindungen | 2 |
| Schwere Atome | 23 |
| Formalladung | 0 |
| Komplexität | 536 |
| Arzneimittel | DEA Schedule III Controlled Substance -> Anabolic steroidsPharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds |
| Endocrine Disruptors | Potential endocrine disrupting compound |
| Physical Description | Solid |
| Schmelzpunkt | 144-145° |
| Siedepunkt | 459.5±45.0 °C(Predicted) |
| Dichte | 1.09±0.1 g/cm3(Predicted) |
| Löslichkeit | soluble in Chloroform, Methanol |
| Aggregatzustand | Solid |
| pKa (Säurekonstante) | 15.13±0.40(Predicted) |
| Farbe | Pale Beige |
Sicherheit & Vorschriften
| Regulatorische Informationen | DEA schedule III controlled substance |
|---|---|
| Toxizität | LD50 orally in mice: >5010 mg/kg (Goldenthal) |
| DEA Controlled Substances | CSCN: 4000CSA SCH: Schedule IIINARC: No |
Anwendungen & Verwendung
Verwenden
An anabolic steroid which encourages weight gain. Controlled Substance